Enoxaparin Sodium Injection 100mg/ml - A Reliable Prophylaxis of Deep Vein Thrombosis
The Enoxaparin Sodium Injection is an anticoagulant drug that is primarily used for the prophylaxis of Deep Vein Thrombosis (DVT). It is also prescribed for the prevention of complications related to unstable angina and myocardial infarction. Representing a class of drugs known as Low Molecular Weight Heparins (LMWH), Enoxaparin hinders the formation of blood clots and thus, safeguards the cardiovascular system.
Product Information
- Molecular Formula: C26H40N2NaO36S5
- CAS Number: 9005-49-6
- Molecular Weight: Approximately 4500 Da
- Protein Binding: Approximately 94%
- Metabolism: Hepatic (liver)
Key Pharmacological Information
- Pharmacological Class: Anticoagulant, Low Molecular Weight Heparin
- Routes of Administration: Subcutaneous Injection
- LD50: Not readily available due to usage via injection. Safe usage guidelines are provided in the dosage instructions.
- Solubility: Soluble in water
- Density: 1.27 g/cm³
Therapeutic Use and Dosage
Enoxaparin Sodium Injection is provided in a concentration of 100mg/ml. The volumes available include 0.2ml, 0.3ml, 0.4ml, and 0.8ml. The dosage regimen depends on the patient's weight, body response, and the overall clinical scenario.
Precautionary Information
- People with active bleeding, history of thrombocytopenia, or hypersensitivity to Enoxaparin should refrain from using this product.
- Regular monitoring of platelets and hemoglobin is recommended during the treatment.
- Pregnant women or breastfeeding mothers should use this drug under medical supervision only.